RENE — ReNeuron Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- £1.93m
- -£2.80m
- £0.53m
C2019 March 31st | 2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Interim Report | ARS | ARS | ARS | ARS |
Standards: | — | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -17.2 | -13.9 | -13.4 | -11.1 | -6.66 |
Depreciation | |||||
Non-Cash Items | -0.024 | 0.652 | 1.26 | 0.482 | 0.118 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 4.93 | -1.51 | 5.72 | 2.84 | -1.21 |
Change in Accounts Receivable | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -11.9 | -14.3 | -6.05 | -7.41 | -7.48 |
Capital Expenditures | -0.239 | -0.119 | -0.025 | -0.302 | -0.22 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.342 | 0.3 | 0.027 | 2.53 | 4.13 |
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.103 | 0.181 | 0.002 | 2.22 | 3.91 |
Financing Cash Flow Items | 4.36 | 6.26 | -8.74 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 4.37 | 6.32 | 8.61 | -0.134 | -0.147 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -7.48 | -7.81 | 2.08 | -5.16 | -3.4 |